1M6MYTD1A5AMAX
Caricamento quotazioni...
Previsioni
| Acquista |
2 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
iSpecimen settles dispute with WestPark Capital by paying $97,500
iSpecimen reached a settlement agreement with WestPark Capital and will pay $97,500 to resolve all claims arising from prior investment banking engagements and an arbitration. WestPark had originally sought $269,999.91 plus interest and costs; the settlement is not an admission of liability. iSpecimen expects to record the payment as an expense in the quarter ended September 30, 2026. The company also reported the closing of a $2.5 million private placement with E.F. Hutton as placement agent. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 133,13K | 78,00% |
| Utile lordo | -116,37K | 151,00% |
| Utile netto | -1,19 Mln | 34,40% |
| EBITDA | -1,02 Mln | 95,21% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 191,67K € |
Numero di azioni | 138,86K |
Massimo/minimo a 52 settimane | 109,74 € - 1,21 € |
| Dividendi | No |
Beta | 1,64 |
Rapporto P/E | -0,03 |
Rapporto PEG | 0,00 |
Rapporto P/B | 1,28 |
Rapporto P/S | 0,48 |
Profilo aziendale
| Nome | iSpecimen Inc |
| CEO | Katharyn Field |
| Dipendenti | 7 |
Scopri gli asset
Gli azionisti di iSpecimen Inc investono anche nei seguenti asset
